BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38084868)

  • 21. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
    Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
    Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-148a/152 cluster restrains tumor stem cell phenotype of colon cancer via modulating CCT6A.
    Peng X; Chen G; Lv B; Lv J
    Anticancer Drugs; 2022 Jan; 33(1):e610-e621. PubMed ID: 34486532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establishment of CoCl2 induced hypoxic cell model of oral squamous cell carcinoma and a preliminary study on the biological behaviour change].
    Han S; Han W; Ni Y; Wang Z; Hu Q
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Mar; 50(3):173-7. PubMed ID: 26081859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
    Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
    Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-340-5p affects oral squamous cell carcinoma (OSCC) cells proliferation and invasion by targeting endoplasmic reticulum stress proteins.
    Ou D; Wu Y; Zhang J; Liu J; Liu Z; Shao M; Guo X; Cui S
    Eur J Pharmacol; 2022 Apr; 920():174820. PubMed ID: 35227681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
    Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semaphorin 4A restricts tumor progression by inhibiting angiogenesis of oral squamous cell carcinoma cells.
    Liu XQ; Yao Y; Mu JW; Yang FY
    Tissue Cell; 2021 Apr; 69():101485. PubMed ID: 33460983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer.
    Sun H; Wang Y; Jing HY; Yang XY; Shi XX; Zhang JH; Yu YX; Gao L; Wang XY; Li WH; Yu L
    Front Genet; 2021; 12():629856. PubMed ID: 34017352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
    Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
    J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A γ-Secretase Inhibitor Attenuates Cell Cycle Progression and Invasion in Human Oral Squamous Cell Carcinoma: An In Vitro Study.
    Pongjantarasatian S; Nowwarote N; Rotchanakitamnuai V; Srirodjanakul W; Saehun R; Janebodin K; Manokawinchoke J; Fournier BPJ; Osathanon T
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
    Yang K; Zhao J; Liu S; Man S
    Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FUT8-AS1/miR-944/Fused in Sarcoma/Transcription Factor 4 Feedback Loop Participates in the Development of Oral Squamous Cell Carcinoma through Activation of Wnt/β-Catenin Signaling Pathway.
    Geng Z; Huang Y; Wu S; Zhu D; Li W
    Am J Pathol; 2023 Feb; 193(2):233-245. PubMed ID: 36697118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of WNT1, NOTCH1, PDGFRβ, and CXCR4 in Oral Squamous Cell Carcinoma.
    Cierpikowski P; Lis-Nawara A; Bar J
    Anticancer Res; 2023 Feb; 43(2):591-602. PubMed ID: 36697060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
    Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
    Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma.
    Lyu Q; Jin L; Yang X; Zhang F
    Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.